121 related articles for article (PubMed ID: 37466243)
1. Fluorescent imaging using novel conjugated polymeric nanoparticles-affimer probes in complex
Jolugbo P; Willott T; Lin WH; Maisey T; O'Callaghan D; Green MA; Jayne DG; Khot MI
Nanoscale; 2023 Aug; 15(30):12476-12480. PubMed ID: 37466243
[TBL] [Abstract][Full Text] [Related]
2. Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle.
Khaled YS; Khot MI; Aiyappa-Maudsley R; Maisey T; Pramanik A; Tiernan J; Lintern N; Al-Enezi E; Shamsuddin SH; Tomlinson D; Coletta L; Millner PA; Hughes TA; Jayne DG
Nanoscale; 2024 Apr; 16(14):7185-7199. PubMed ID: 38506227
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the tumor-targeting specific imaging and killing effect of a CEA-targeting nanoparticle in colorectal cancer.
Feng Q; Wang SA; Ning B; Xie J; Ding J; Liu S; Ai S; Li F; Wang X; Guan W
Biochem Biophys Res Commun; 2024 Jul; 719():150084. PubMed ID: 38733742
[TBL] [Abstract][Full Text] [Related]
4. CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models.
Tiernan JP; Ingram N; Marston G; Perry SL; Rushworth JV; Coletta PL; Millner PA; Jayne DG; Hughes TA
Nanomedicine (Lond); 2015; 10(8):1223-31. PubMed ID: 25694062
[TBL] [Abstract][Full Text] [Related]
5. Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen.
Levin LV; Griffin TW
Cancer Lett; 1991 Nov; 60(2):143-52. PubMed ID: 1657369
[TBL] [Abstract][Full Text] [Related]
6. Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.
da Paz MC; Santos Mde F; Santos CM; da Silva SW; de Souza LB; Lima EC; Silva RC; Lucci CM; Morais PC; Azevedo RB; Lacava ZG
Int J Nanomedicine; 2012; 7():5271-82. PubMed ID: 23055733
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells.
Pereira I; Sousa F; Kennedy P; Sarmento B
Int J Pharm; 2018 Oct; 549(1-2):397-403. PubMed ID: 30110619
[TBL] [Abstract][Full Text] [Related]
9. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
[TBL] [Abstract][Full Text] [Related]
10. Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using
Pramanik A; Xu Z; Shamsuddin SH; Khaled YS; Ingram N; Maisey T; Tomlinson D; Coletta PL; Jayne D; Hughes TA; Tyler AII; Millner PA
ACS Appl Mater Interfaces; 2022 Mar; 14(9):11078-11091. PubMed ID: 35196008
[TBL] [Abstract][Full Text] [Related]
11. Intra-colonic administration of a polymer-bound NIRF probe for improved colorectal cancer detection during colonoscopy.
Kogan-Zviagin I; Shamay Y; Nissan A; Sella-Tavor O; Golan M; David A
J Control Release; 2014 Oct; 192():182-91. PubMed ID: 25008468
[TBL] [Abstract][Full Text] [Related]
12. Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.
Abdul-Wahid A; Cydzik M; Fischer NW; Prodeus A; Shively JE; Martel A; Alminawi S; Ghorab Z; Berinstein NL; Gariépy J
Int J Cancer; 2018 Oct; 143(8):1963-1977. PubMed ID: 29756328
[TBL] [Abstract][Full Text] [Related]
13. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer.
Eftekhar E; Naghibalhossaini F
Mol Biol Rep; 2014 Jan; 41(1):459-66. PubMed ID: 24293105
[TBL] [Abstract][Full Text] [Related]
15. scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells.
Silveira MJ; Martins C; Cruz T; Castro F; Amorim-Costa Â; Chester K; Oliveira MJ; Sarmento B
J Nanobiotechnology; 2023 Oct; 21(1):357. PubMed ID: 37784150
[TBL] [Abstract][Full Text] [Related]
16. Targeted Biodegradable Near-Infrared Fluorescent Nanoparticles for Colorectal Cancer Imaging.
Chung SJ; Hadrick K; Nafiujjaman M; Apu EH; Hill ML; Nurunnabi M; Contag CH; Kim T
ACS Appl Bio Mater; 2024 Apr; ():. PubMed ID: 38574012
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
[TBL] [Abstract][Full Text] [Related]
18. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.
Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW
Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling.
Samara RN; Laguinge LM; Jessup JM
Cancer Res; 2007 May; 67(10):4774-82. PubMed ID: 17510406
[TBL] [Abstract][Full Text] [Related]
20. A review of tumor-specific fluorescence-guided surgery for colorectal cancer.
Hollandsworth HM; Turner MA; Hoffman RM; Bouvet M
Surg Oncol; 2021 Mar; 36():84-90. PubMed ID: 33316684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
